Department of Pharmacological Sciences, Stony Brook University, Renaissance School of Medicine, Basic Science Tower 8-140, Stony Brook, New York, 11794, USA
Auto-generated profile, based on publicly available information
Jason Luis Quiñones
Department of Pharmacological Sciences, Stony Brook University, Renaissance School of Medicine, Basic Science Tower 8-140, Stony Brook, New York, 11794, USA
Free radical attack on the C1′ position of DNA deoxyribose generates the oxidized abasic (AP) site 2-deoxyribonolactone (dL). Upon encountering dL, AP lyase enzymes such as DNA polymerase β (Polβ) form dead-end, covalent intermediates in vitro during attempted DNA repair. However, the conditions that lead to the in vivo formation of such DNA–protein cross-links (DPC), and their impact on cellular functions, have remained unknown. We adapted an immuno-slot blot approach to detect oxidative Polβ-DPC in vivo. Treatment of mammalian cells with genotoxic oxidants that generate dL in DNA led to the formation of Polβ-DPC in vivo. In a dose-dependent fashion, Polβ-DPC were detected in MDA-MB-231 human cells treated with the antitumor drug tirapazamine (TPZ; much more Polβ-DPC under 1% O2 than under 21% O2) and even more robustly with the “chemical nuclease” 1,10-copper-ortho-phenanthroline, Cu(OP)2. Mouse embryonic fibroblasts challenged with TPZ or Cu(OP)2 also incurred Polβ-DPC. Nonoxidative agents did not generate Polβ-DPC. The cross-linking in vivo was clearly a result of the base excision DNA repair pathway: oxidative Polβ-DPC depended on the Ape1 AP endonuclease, which generates the Polβ lyase substrate, and they required the essential lysine-72 in the Polβ lyase active site. Oxidative Polβ-DPC had an unexpectedly short half-life (∼30 min) in both human and mouse cells, and their removal was dependent on the proteasome. Proteasome inhibition under Cu(OP)2 treatment was significantly more cytotoxic to cells expressing wild-type Polβ than to cells with the lyase-defective form. That observation underscores the genotoxic potential of oxidative Polβ-DPC and the biological pressure to repair them. Significance Oxidative DNA damage is a by-product of aerobic metabolism and various genotoxic agents, including many cancer therapy regimens. Important DNA lesions include 2-deoxyribonolactone (dL), a major type of oxidized abasic (AP) site. In addition to the cytotoxic and mutagenic effects of non-oxidized AP sites, dL poses another threat: in vitro, dL traps some DNA repair enzymes in covalent DNA–protein cross-links (DPC) via their AP lyase activity. A prime example is DNA polymerase β (Polβ), which is critical for base excision DNA repair. Here we show that oxidative Polβ-DPC form robustly during attempted DNA repair in mammalian cells treated with dL-inducing oxidants. Mammalian cells remove Polβ-DPC surprisingly rapidly by a mechanism dependent on proteasome activity. Their accumulation is toxic.
Mercury flux from HgCl2–treated sand and untreated soil samples of varying thickness (0.5–15 mm) were measured in dark and light under a Teflon dynamic flux chamber. Mean emissions over a 5.5‐d sampling period showed an increase with depth for sand samples between 0.5 and 2 mm, but increasing depth above 2 mm had no effect. First‐order kinetic models showed strong goodness of fit to the data and explained a high degree of variability in the emissions profile of all sand samples (R2 = 0.70–0.98). Soil samples showed an initial emissions peak that was not correlated with depth, suggesting a very shallow process at work. However, longer‐term “baseline” emissions, measured as mean emissions between Days 4.5 and 5.5, did show a relationship with depth. First‐order kinetic models showed good fit for soil samples up to 4 mm thick (R2 = 0.66–0.91); however, thicker samples did not show a consistent fit to first‐ or second‐order kinetic models (1° R2 = 0.00–0.46; 2° R2 = 0.00–0.54). The data suggest that mercury emissions from soil samples may follow a multicomponent model for which more than one component is affected by incident radiation.